|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02877 SHINEWAY PHARM
Nominal 
8.430 -0.150 (-1.748%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 1,652,698 | -20.798% | 2,086,695 | 2,398,680 | 1,815,194 | 1,554,097 |
| Cost of Sales | (459,092) | -10.771% | (514,511) | (594,723) | (490,380) | (407,067) |
| Gross Profit | 1,193,606 | -24.080% | 1,572,184 | 1,803,957 | 1,324,814 | 1,147,030 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 1,835 | -- | (4,286) | (6,236) | (1,443) | (525) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 774,678 | -10.139% | 862,083 | 671,288 | 411,408 | 380,422 | |
| Taxation | (160,015) | -32.083% | (235,604) | (179,823) | (80,285) | (71,966) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 614,663 | -1.886% | 626,479 | 491,465 | 331,123 | 308,456 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (113,957) | -3.688% | (118,321) | 171 | (52,678) | (45,821) |
| Depreciation & Amortisation | 73,935 | -8.358% | 80,678 | 86,102 | 93,868 | 89,331 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 81.000 | -2.410% | 83.000 | 65.000 | 44.000 | 41.000 |
| DPS (cts) | 47.000 | -- | 54.000 | 42.000 | 32.000 | 39.000 |
| Dividend Payout Ratio (%) | 58.025% | -- | 65.060% | 64.615% | 72.727% | 95.122% |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 9.443 | -- | 8.871 | 8.029 | 7.345 | 7.192 |
| Remarks: | Real time quote last updated: 04/09/2025 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 614,663 |
| %Change | -1.886% |
| EPS / (LPS) | RMB 0.810 |
| NBV Per Share (¥) | RMB 9.443 |